Article Details
Retrieved on: 2018-01-31 20:00:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>“Avrobio has made remarkable progress with its gene therapy platform, including a very compelling initial clinical response in the first patient with Fabry disease to receive the company's lead gene therapy candidate,” said Bruce Booth, partner at <b>Atlas Venture</b>, which participated in the financing.</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here